Maternal Microchimerism Protects Hemophilia A Patients from Inhibitor Development

Overview

Journal Blood Adv

Specialty Hematology

Date 2020 May 7

PMID 32374877

Citations 2

Authors

Yeling Lu

Zhenping Chen

Jing Dai

Xi Wu

Hao Gu

Zekun Li

Jian Li

Qiulan Ding

Wenman Wu

Runhui Wu

Xuefeng Wang

Affiliations

Soon will be listed here.

Citing Articles

Hemophilia a patients with inhibitors: Mechanistic insights and novel therapeutic implications.

Luo L, Zheng Q, Chen Z, Huang M, Fu L, Hu J Front Immunol. 2022; 13:1019275.

PMID: 36569839 PMC: 9774473. DOI: 10.3389/fimmu.2022.1019275.

Savior Siblings Might Rescue Fetal Lethality But Not Adult Lymphoma in Irf2bp2-Null Mice.

Vilmundarson R, Heydarikhorneh N, Duong A, Ho T, Keyhanian K, Soheili F Front Immunol. 2022; 13:868053.

PMID: 35865523 PMC: 9295810. DOI: 10.3389/fimmu.2022.868053.

References

Mold J, Venkatasubrahmanyam S, Burt T, Michaelsson J, Rivera J, Galkina S . Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science. 2010; 330(6011):1695-9. PMC: 3276679. DOI: 10.1126/science.1196509. View

Gouw S, Fijnvandraat K . Unraveling the genetics of inhibitors in hemophilia. Blood. 2013; 121(8):1250-1. DOI: 10.1182/blood-2012-12-472647. View

Dutta P, Burlingham W . Stem cell microchimerism and tolerance to non-inherited maternal antigens. Chimerism. 2010; 1(1):2-10. PMC: 2995256. DOI: 10.4161/chim.1.1.12667. View

Nisen P, Waber P . Nonrandom X chromosome DNA methylation patterns in hemophiliac females. J Clin Invest. 1989; 83(4):1400-3. PMC: 303834. DOI: 10.1172/JCI114028. View

Kinder J, Jiang T, Ertelt J, Xin L, Strong B, Shaaban A . Cross-Generational Reproductive Fitness Enforced by Microchimeric Maternal Cells. Cell. 2015; 162(3):505-15. PMC: 4522363. DOI: 10.1016/j.cell.2015.07.006. View

Gouw S, van der Bom J, van den Berg H, Zewald R, Ploos van Amstel J, Mauser-Bunschoten E . Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients. Haemophilia. 2010; 17(2):275-81. DOI: 10.1111/j.1365-2516.2010.02420.x. View

Claas F, Gijbels Y, van Rood J . Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science. 1988; 241(4874):1815-7. DOI: 10.1126/science.3051377. View

Dutta P, Burlingham W . Tolerance to noninherited maternal antigens in mice and humans. Curr Opin Organ Transplant. 2009; 14(4):439-47. PMC: 2892989. DOI: 10.1097/MOT.0b013e32832d6683. View

Garagiola I, Palla R, Peyvandi F . Risk factors for inhibitor development in severe hemophilia a. Thromb Res. 2018; 168:20-27. DOI: 10.1016/j.thromres.2018.05.027. View

10.

Kieback E, Hilgenberg E, Stervbo U, Lampropoulou V, Shen P, Bunse M . Thymus-Derived Regulatory T Cells Are Positively Selected on Natural Self-Antigen through Cognate Interactions of High Functional Avidity. Immunity. 2016; 44(5):1114-26. DOI: 10.1016/j.immuni.2016.04.018. View

11.

Arruda V . The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia A. Haematologica. 2015; 100(7):849-50. PMC: 4486216. DOI: 10.3324/haematol.2015.129858. View

12.

Nelson J . The otherness of self: microchimerism in health and disease. Trends Immunol. 2012; 33(8):421-7. PMC: 3516290. DOI: 10.1016/j.it.2012.03.002. View

13.

Astermark J . FVIII inhibitors: pathogenesis and avoidance. Blood. 2015; 125(13):2045-51. PMC: 4416939. DOI: 10.1182/blood-2014-08-535328. View

14.

Zanolini D, Merlin S, Feola M, Ranaldo G, Amoruso A, Gaidano G . Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A. Haematologica. 2015; 100(7):881-92. PMC: 4486222. DOI: 10.3324/haematol.2014.123117. View

15.

DESAI R, CREGER W . Maternofetal passage of leukocytes and platelets in man. Blood. 1963; 21:665-73. View

16.

Evans G, Morgan R . Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A. Proc Natl Acad Sci U S A. 1998; 95(10):5734-9. PMC: 20448. DOI: 10.1073/pnas.95.10.5734. View

17.

Chen Y, Schroeder J, Chen J, Luo X, Baumgartner C, Montgomery R . The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunity. Blood. 2015; 127(10):1346-54. PMC: 4786841. DOI: 10.1182/blood-2015-08-662916. View

18.

Collins P, Palmer B, Chalmers E, Hart D, Liesner R, Rangarajan S . Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011. Blood. 2014; 124(23):3389-97. PMC: 4246037. DOI: 10.1182/blood-2014-07-580498. View

19.

Mold J, Michaelsson J, Burt T, Muench M, Beckerman K, Busch M . Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science. 2008; 322(5907):1562-5. PMC: 2648820. DOI: 10.1126/science.1164511. View

20.

Nelson J, Gillespie K, Lambert N, Stevens A, Loubiere L, Rutledge J . Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci U S A. 2007; 104(5):1637-42. PMC: 1785262. DOI: 10.1073/pnas.0606169104. View